4//SEC Filing
Hesslein Robert W. 4
Accession 0001735276-25-000035
CIK 0001178670other
Filed
Mar 4, 7:00 PM ET
Accepted
Mar 5, 4:23 PM ET
Size
7.6 KB
Accession
0001735276-25-000035
Insider Transaction Report
Form 4
Hesslein Robert W.
EVP, CLO and Secretary
Transactions
- Award
Common Stock
2025-03-03+757→ 8,002 total - Award
Stock Option (right to buy)
2025-03-03+1,529→ 1,529 totalExercise: $243.53Exp: 2035-03-03→ Common Stock (1,529 underlying)
Footnotes (2)
- [F1]These shares are represented by restricted stock units (RSUs) granted under the Amended and Restated 2018 Stock Incentive Plan. Each RSU represents a contingent right to receive one share of common stock. The RSUs will vest over a three-year period, with one third vesting on each of the first, second and third anniversaries of the grant date, subject to the Reporting Persons continuous service with the Issuer as of each such vesting date.
- [F2]The stock option vests as to 25% of the shares on the first anniversary of the grant date and the remaining shares vest in equal installments at the end of each successive three-month period thereafter until the fourth anniversary of the grant date, subject to the Reporting Persons continuous service with the Issuer as of each such vesting date.
Documents
Issuer
ALNYLAM PHARMACEUTICALS, INC.
CIK 0001178670
Entity typeother
Related Parties
1- filerCIK 0001585018
Filing Metadata
- Form type
- 4
- Filed
- Mar 4, 7:00 PM ET
- Accepted
- Mar 5, 4:23 PM ET
- Size
- 7.6 KB